Is C3R suitable for all keratoconus patients?
C3R is a relatively new treatment and its place in the treatment of keratoconus is still being defined. This will become more apparent as more people are treated around the world and the results of these treatments are published. To date, the published literature suggests that C3R is most suited to patients with progressive keratoconus. That means patients whose glasses or contact lens prescription is changing quite frequently, or whose vision is becoming worse despite using contact lenses, or whose corneal topography maps show clear progression of keratoconus.
